name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
1CE1_HL_P_27_11.pdb,1CE1,10366506,1.90,Q6PYX1,PF07654,2.60.40.10,HL,431,P,7,TSSPSAD,CCTTTTC,1101002,27,11,1,CCCCCCC,7,0,A:0;E:0;F:0;G:0;H:0;I:0;N:0;P:0;R:0;S:0;T:0;Y:0,A:0;E:0;F:0;G:0;H:0;I:0;N:0;P:0;R:0;S:0;T:0;Y:0,A:5;D:4;E:3;G:9;K:12;L:1;N:4;P:1;Q:3;R:3;S:19;T:4,A:18;C:8;D:13;E:10;F:16;G:20;H:4;I:11;K:14;L:31;M:3;N:12;P:23;Q:21;R:8;S:39;T:37;V:37;W:6;Y:16,C:0;E:0;T:0,C:0;E:0;T:0,B:1;C:15;E:7;G:10;H:4;T:31,B:7;C:56;E:206;G:13;H:7;T:52;b:6,27_11,A:1;E:1;F:1;G:1;H:2;I:1;N:1;P:1;R:3;S:1;T:1;Y:2,C:3;E:1;T:12,A:0;E:0;F:0;G:0;H:0;I:0;N:0;P:0;R:0;S:0;T:0;Y:0,C:0;E:0;T:0,5433358,ALA_106_H_COREBINDING;ARG_52_H_COREBINDING;ARG_94_L_COREBINDING;ARG_96_L_COREBINDING;ASN_50_L_COREBINDING;GLU_101_H_COREBINDING;GLY_102_H_COREBINDING;HIS_103_H_COREBINDING;HIS_91_L_COREBINDING;ILE_92_L_COREBINDING;PHE_50_H_COREBINDING;PRO_107_H_COREBINDING;SER_93_L_COREBINDING;THR_104_H_COREBINDING;TYR_32_L_COREBINDING;TYR_33_H_COREBINDING,GTSSPSAD,-1,0.561421186071831,,9999999,THR_1_P_C;SER_2_P_C;SER_3_P_C;PRO_4_P_C;SER_5_P_C;ALA_6_P_C;ASP_7_P_C,"19A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH1H FAB IN COMPLEX 2 WITH A SYNTHETIC PEPTIDE ANTIGEN"
2HRP_HL_P_27_8.pdb,2HRP,9150407,2.20,,,2.60.40.10,HL,441,P,10,MSLPGRWKPK,CCBTTTEEEC,3201000213,27,8,1,CCCCCCCCCC,10,0,D:0;E:0;F:0;G:0;K:0;R:0;S:0;T:0;V:0;W:0;Y:0,D:0;E:0;F:0;G:0;K:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:4;D:10;E:4;G:9;K:10;M:1;N:5;P:3;Q:3;R:4;S:21;T:4,A:23;C:8;D:10;E:11;F:16;G:25;H:7;I:13;K:10;L:27;M:8;N:9;P:24;Q:15;R:12;S:39;T:33;V:32;W:7;Y:13,C:0;E:0;T:0,C:0;E:0;T:0,C:15;E:10;G:8;H:4;T:41,B:5;C:45;E:220;G:7;H:7;T:54;b:4,27_8,D:1;E:2;F:1;G:1;K:2;R:1;S:2;T:2;V:1;W:1;Y:7,C:2;E:11;T:8,D:0;E:0;F:0;G:0;K:0;R:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;T:0,7545444679,ARG_104_H_COREBINDING;ASP_106_H_COREBINDING;GLU_103_H_COREBINDING;GLU_97_L_COREBINDING;GLY_107_H_COREBINDING;LYS_34_L_COREBINDING;LYS_96_L_COREBINDING;PHE_36_L_COREBINDING;SER_95_L_COREBINDING;SER_99_H_COREBINDING;THR_108_H_COREBINDING;THR_57_H_COREBINDING;TRP_100_L_COREBINDING;TYR_105_H_COREBINDING;TYR_109_H_COREBINDING;TYR_110_H_COREBINDING;TYR_31_L_COREBINDING;TYR_32_L_COREBINDING;TYR_50_H_COREBINDING;TYR_59_H_COREBINDING;VAL_98_L_COREBINDING,MSLPGRWKPK,-1,0.52462395214496,,9999999999,MET_1_P_C;SER_2_P_C;LEU_3_P_C;PRO_4_P_C;GLY_5_P_C;ARG_6_P_C;TRP_7_P_C;LYS_8_P_C;PRO_9_P_C;LYS_10_P_C,"ANTIGENANTIBODY COMPLEX"
2QHR_HL_P_27_6.pdb,2QHR,18005986,2.00,P01844,PF07654,2.60.40.10,HL,440,P,11,VEQHHRRTDND,CCCCCCCCCCC,23021010032,27,6,1,CCCCCCCCCCC,11,0,D:0;F:0;G:0;H:0;I:0;Q:0;R:0;S:0;T:0;Y:0,D:0;F:0;G:0;H:0;I:0;Q:0;R:0;S:0;T:0;Y:0,A:3;C:1;D:6;E:8;G:11;K:12;L:1;N:4;P:6;Q:4;R:3;S:19;T:5,A:20;C:8;D:9;E:11;F:13;G:21;H:6;I:13;K:12;L:30;M:6;N:7;P:19;Q:13;R:7;S:44;T:36;V:34;W:8;Y:14,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:26;E:10;G:8;H:8;T:31,B:5;C:49;E:218;G:14;H:9;T:32;b:4,27_6,D:2;F:1;G:4;H:3;I:1;Q:1;R:1;S:2;T:3;Y:8,C:7;E:7;G:2;T:10,D:0;F:0;G:0;H:0;I:0;Q:0;R:0;S:0;T:0;Y:0,C:0;E:0;G:0;T:0,66434333565,ARG_53_H_COREBINDING;ASP_33_H_COREBINDING;ASP_96_L_COREBINDING;GLN_27_L_COREBINDING;GLY_54_H_COREBINDING;GLY_55_H_COREBINDING;GLY_56_H_COREBINDING;GLY_95_L_COREBINDING;HIS_106_H_COREBINDING;HIS_28_L_COREBINDING;HIS_99_H_COREBINDING;ILE_100_H_COREBINDING;PHE_102_L_COREBINDING;SER_105_H_COREBINDING;SER_52_H_COREBINDING;THR_30_L_COREBINDING;THR_32_L_COREBINDING;THR_97_L_COREBINDING;TYR_101_H_COREBINDING;TYR_102_H_COREBINDING;TYR_107_H_COREBINDING;TYR_108_H_COREBINDING;TYR_31_L_COREBINDING;TYR_50_H_COREBINDING;TYR_57_H_COREBINDING;TYR_59_H_COREBINDING,VEQHHRRTDND,-1,0.442879914203444,,99999999999,VAL_1_P_C;GLU_2_P_C;GLN_3_P_C;HIS_4_P_C;HIS_5_P_C;ARG_6_P_C;ARG_7_P_C;THR_8_P_C;ASP_9_P_C;ASN_10_P_C;ASP_11_P_C,"CRYSTAL STRUCTURE OF THE 13F612 FAB FRAGMENT BOUND TO ITS 2 EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE"
3BKJ_HL_A_27_12.pdb,3BKJ,18237744,1.59,P84751_A2NHM3,PF07654_PF07686,2.60.40.10,HL,442,A,7,AEFRHDS,CBCCCCC,4101014,27,12,1,CCCCCCC,7,0,A:0;D:0;E:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,A:0;D:0;E:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,A:4;C:1;D:7;E:2;G:8;K:9;L:1;N:2;P:2;Q:4;R:3;S:19;T:5,A:14;C:8;D:13;E:14;F:16;G:22;H:6;I:15;K:14;L:34;M:4;N:10;P:22;Q:10;R:14;S:43;T:41;V:32;W:7;Y:16,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:16;E:7;G:8;H:6;T:30,B:6;C:57;E:216;G:13;H:10;T:49;b:4,27_12,A:1;D:2;E:1;H:2;L:2;N:2;R:2;S:2;V:1;W:2;Y:3,B:1;C:3;E:4;T:12,A:0;D:0;E:0;H:0;L:0;N:0;R:0;S:0;V:0;W:0;Y:0,B:0;C:0;E:0;T:0,6544567,ALA_96_L_COREBINDING;ARG_104_H_COREBINDING;ARG_99_H_COREBINDING;ASN_109_H_COREBINDING;ASN_33_L_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;GLU_107_H_COREBINDING;HIS_31_L_COREBINDING;HIS_51_H_COREBINDING;LEU_101_L_COREBINDING;LEU_98_L_COREBINDING;SER_32_L_COREBINDING;SER_97_L_COREBINDING;TRP_48_H_COREBINDING;TRP_54_H_COREBINDING;TYR_106_H_COREBINDING;TYR_37_L_COREBINDING;TYR_53_H_COREBINDING;VAL_99_L_COREBINDING,DAEFRHDSGYEVHHQK,-1,0.501508295625943,,9999999,ALA_1_A_C;GLU_2_A_C;PHE_3_A_C;ARG_4_A_C;HIS_5_A_C;ASP_6_A_C;SER_7_A_C,"CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN 2 OF AMYLOID BETA PEPTIDE 116"
3DRQ_AB_C_27_1.pdb,3DRQ,18824005,2.00,Q6PYX1,PF07654,2.60.40.10,AB,429,C,8,LELDKWAS,CEETTTTC,22101115,27,1,2,eCCCCCdd,5,2,A:0;D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,A:1;D:0;F:0;G:0;H:0;L:1;P:0;R:0;V:0;Y:0,A:1;D:2;E:5;G:10;K:11;L:1;N:2;P:6;Q:3;R:4;S:19;T:8;V:1,A:21;C:8;D:15;E:10;F:14;G:19;H:5;I:12;K:9;L:33;M:2;N:10;P:23;Q:16;R:12;S:39;T:37;V:36;W:6;Y:13,C:0;E:0;T:0,C:2;E:0;T:0,C:19;E:10;G:5;H:4;T:35,B:5;C:50;E:204;G:10;H:7;T:58;b:6,27_1,A:0;D:1;F:2;G:2;H:2;L:1;P:1;R:2;V:1;Y:2,C:4;E:5;T:5,A:0;D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,C:0;E:0;T:0,87766678,ALA_1_A_exosite;ARG_100_B_COREBINDING;ARG_60_B_COREBINDING;ASP_56_B_COREBINDING;GLY_102_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_2_A_exosite;LEU_91_A_COREBINDING;PHE_32_B_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_108_B_COREBINDING,GIGALFLGFLGAAGSKKKNEQELLELDKWASLWN,0.997674418604651,0.243651117824938,2.09246266394409,99999999,LEU_1_C_e;GLU_2_C_C;LEU_3_C_C;ASP_4_C_C;LYS_5_C_C;TRP_6_C_C;ALA_7_C_e;SER_8_C_e,"CRYSTAL STRUCTURE OF THE HIV1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN 2 COMPLEX WITH THE GP41 FPMPER HYB3K CONSTRUCT 3 514GIGALFLGFLGAAGS528KKAHX655KNEQELLELDKWASLWN671 SOAKED IN PEG2 4 PROPANOL SOLUTION"
3GO1_HL_P_27_2.pdb,3GO1,20622876,1.89,,,2.60.40.10,HL,431,P,14,RKRIHIGPGRAFYT,CCCCCCTTTTCCCC,30200111004245,27,2,1,CCCCCCCCCCCCCC,14,0,A:0;D:0;E:0;G:0;K:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:0;D:0;E:0;G:0;K:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,A:6;D:2;E:6;F:1;G:11;K:11;N:3;P:7;Q:2;R:3;S:20;T:5;V:1,A:25;C:8;D:8;E:11;F:9;G:22;H:6;I:11;K:11;L:30;M:1;N:8;P:24;Q:16;R:8;S:34;T:36;V:37;W:7;Y:16,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,B:1;C:19;E:11;G:11;H:5;T:31,B:8;C:56;E:195;G:12;H:7;T:46;b:4,27_2,A:1;D:3;E:1;G:2;K:1;L:1;N:3;Q:1;S:3;T:1;V:1;W:1;Y:6,C:5;E:9;G:2;T:9,A:0;D:0;E:0;G:0;K:0;L:0;N:0;Q:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,98876667789999,ALA_100_H_COREBINDING;ASN_107_H_COREBINDING;ASN_29_L_COREBINDING;ASN_58_H_COREBINDING;ASP_104_H_COREBINDING;ASP_50_L_COREBINDING;ASP_91_L_COREBINDING;GLN_30_L_COREBINDING;GLU_98_H_COREBINDING;GLY_106_H_COREBINDING;GLY_94_L_COREBINDING;LEU_27_L_COREBINDING;LYS_49_L_COREBINDING;SER_28_L_COREBINDING;SER_92_L_COREBINDING;SER_93_L_COREBINDING;THR_65_L_COREBINDING;TRP_99_H_COREBINDING;TYR_31_L_COREBINDING;TYR_33_H_COREBINDING;TYR_33_L_COREBINDING;TYR_50_H_COREBINDING;TYR_52_H_COREBINDING;TYR_96_L_COREBINDING;VAL_56_H_COREBINDING,RKRIHIGPGRAFYT,-1,0.483160000778529,,99999999999999,ARG_1_P_C;LYS_2_P_C;ARG_3_P_C;ILE_4_P_C;HIS_5_P_C;ILE_6_P_C;GLY_7_P_C;PRO_8_P_C;GLY_9_P_C;ARG_10_P_C;ALA_11_P_C;PHE_12_P_C;TYR_13_P_C;THR_14_P_C,"CRYSTAL STRUCTURE OF ANTIHIV1 FAB 268D IN COMPLEX WITH V3 PEPTIDE 2 MN"
3IDI_AB_C_27_1.pdb,3IDI,19740978,2.10,,,2.60.40.10,AB,430,C,5,-ALDKW--,-CBCCC--,-32023--,27,1,2,-CCCCC--,5,0,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,A:2;D:5;E:5;F:1;G:9;K:10;L:1;N:2;P:8;Q:3;R:5;S:21;T:8;V:1,A:21;C:8;D:11;E:10;F:14;G:20;H:5;I:12;K:10;L:34;M:2;N:10;P:21;Q:16;R:12;S:38;T:37;V:36;W:6;Y:13,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:20;E:10;G:7;H:4;T:40,B:6;C:53;E:204;G:11;H:8;T:48;b:6,27_1,D:2;F:1;G:2;H:2;L:1;P:1;R:1;V:1;Y:2,B:1;C:4;E:2;T:6,D:0;F:0;G:0;H:0;L:0;P:0;R:0;V:0;Y:0,B:0;C:0;E:0;T:0,-99999--,ARG_100_B_COREBINDING;ASP_56_B_COREBINDING;ASP_58_B_COREBINDING;GLY_106_B_COREBINDING;GLY_33_B_COREBINDING;HIS_92_A_COREBINDING;HIS_96_A_COREBINDING;LEU_91_A_COREBINDING;PHE_93_A_COREBINDING;PRO_103_B_COREBINDING;TYR_54_B_COREBINDING;TYR_94_A_COREBINDING;VAL_108_B_COREBINDING,ALDKWQN,0.997674418604651,0.245629716212208,,-99999--,ALA_1_C_C;LEU_2_C_C;ASP_3_C_C;LYS_4_C_C;TRP_5_C_C,"CRYSTAL STRUCTURE OF THE HIV1 CROSS NEUTRALIZING MONOCLONAL 2 ANTIBODY 2F5 FAB FRAGMENT IN COMPLEX WITH GP41 PEPTIDE 3 ALDKWNQ"
4G6A_HL_A_27_5.pdb,4G6A,22973046,2.50,,,2.60.40.10,HL,439,A,12,QLINTNGSWHIN,CCEEETTEEECC,300012010124,27,5,1,CCCCCCCCCCCC,12,0,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,A:4;C:2;D:3;E:4;G:11;K:11;L:2;N:2;P:4;Q:2;R:3;S:21;T:5,A:22;C:8;D:13;E:12;F:12;G:19;H:5;I:11;K:13;L:36;M:2;N:14;P:20;Q:19;R:8;S:43;T:38;V:32;W:6;Y:17,C:0;E:0;T:0,C:0;E:0;T:0,C:16;E:8;G:8;H:3;T:39,B:5;C:59;E:214;G:10;H:8;T:50;b:4,27_5,D:1;F:1;I:1;N:3;T:1;V:1;W:1;Y:6,C:2;E:5;T:8,D:0;F:0;I:0;N:0;T:0;V:0;W:0;Y:0,C:0;E:0;T:0,877655556679,ASN_34_L_COREBINDING;ASN_95_L_COREBINDING;ASN_96_L_COREBINDING;ASP_98_L_COREBINDING;ILE_98_H_COREBINDING;PHE_36_L_COREBINDING;THR_100_H_COREBINDING;TRP_100_L_COREBINDING;TYR_103_H_COREBINDING;TYR_32_L_COREBINDING;TYR_33_H_COREBINDING;TYR_50_H_COREBINDING;TYR_53_H_COREBINDING;TYR_58_H_COREBINDING;VAL_97_L_COREBINDING,RQLINTNGSWHIN,-1,0.552512868086244,,999999999399,GLN_1_A_C;LEU_2_A_C;ILE_3_A_C;ASN_4_A_C;THR_5_A_C;ASN_6_A_C;GLY_7_A_C;SER_8_A_C;TRP_9_A_C;HIS_10_A_C;ILE_11_A_C;ASN_12_A_C,"STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33"
4GW1_DC_F_27_4.pdb,4GW1,24101516,2.24,,,2.60.40.10,DC,433,F,12,CQFDLSTRRLKC,CCEETTTTEECC,220001000021,27,4,1,CCCCCCCCCCCC,12,0,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;Y:0,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;Y:0,A:2;D:3;E:2;G:7;K:9;L:1;N:4;P:2;Q:3;R:1;S:22;T:5;V:1;W:1;Y:2,A:16;C:8;D:11;E:11;F:16;G:21;H:6;I:12;K:13;L:32;M:1;N:17;P:19;Q:17;R:9;S:43;T:28;V:34;W:7;Y:15,C:0;E:0;T:0,C:0;E:0;T:0,C:18;E:9;G:8;H:3;T:27,B:7;C:49;E:199;G:13;H:8;T:56;b:4,27_4,A:4;D:1;E:3;G:4;I:3;K:1;L:1;N:1;P:2;Q:3;R:2;S:2;T:3;Y:2,C:12;E:14;T:6,A:0;D:0;E:0;G:0;I:0;K:0;L:0;N:0;P:0;Q:0;R:0;S:0;T:0;Y:0,C:0;E:0;T:0,997678765689,ALA_100_C_COREBINDING;ALA_174_D_COREBINDING;ALA_84_C_COREBINDING;ALA_91_D_COREBINDING;ARG_142_C_COREBINDING;ARG_39_C_COREBINDING;ASN_41_C_COREBINDING;ASP_85_C_COREBINDING;GLN_111_D_COREBINDING;GLN_38_C_COREBINDING;GLN_39_D_COREBINDING;GLU_105_C_COREBINDING;GLU_154_D_COREBINDING;GLU_165_C_COREBINDING;GLY_101_C_COREBINDING;GLY_112_D_COREBINDING;GLY_42_C_COREBINDING;GLY_42_D_COREBINDING;ILE_10_C_COREBINDING;ILE_83_C_COREBINDING;ILE_92_D_COREBINDING;LEU_114_D_COREBINDING;LYS_103_C_COREBINDING;PRO_173_D_COREBINDING;PRO_41_D_COREBINDING;SER_40_D_COREBINDING;SER_43_C_COREBINDING;THR_102_C_COREBINDING;THR_40_C_COREBINDING;THR_90_D_COREBINDING;TYR_87_C_COREBINDING;TYR_94_D_COREBINDING,CQFDLSTRRLKC,-1,0.549428058086167,,999999999999,CYS_1_F_C;GLN_2_F_C;PHE_3_F_C;ASP_4_F_C;LEU_5_F_C;SER_6_F_C;THR_7_F_C;ARG_8_F_C;ARG_9_F_C;LEU_10_F_C;LYS_11_F_C;CYS_12_F_C,"CQFD MEDITOPE"
4J8R_DC_J_27_10.pdb,4J8R,23629842,2.30,,,2.60.40.10,DC,430,J,8,PHGGSWGQ,CCCBCCCC,03112023,27,10,1,CCCCCCCC,8,0,A:0;D:0;G:0;L:0;N:0;P:0;S:0;T:0;W:0;Y:0,A:0;D:0;G:0;L:0;N:0;P:0;S:0;T:0;W:0;Y:0,A:5;D:5;E:4;F:1;G:10;H:1;K:11;L:1;N:2;P:5;Q:4;R:4;S:17;T:4;V:1,A:22;C:8;D:14;E:11;F:13;G:21;H:5;I:13;K:15;L:22;M:6;N:13;P:18;Q:13;R:7;S:40;T:39;V:35;W:7;Y:16,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:23;E:10;G:8;H:3;T:31,B:5;C:62;E:199;G:10;H:8;T:50;b:4,27_10,A:4;D:1;G:1;L:1;N:1;P:1;S:2;T:1;W:1;Y:4,B:1;C:7;E:6;T:3,A:0;D:0;G:0;L:0;N:0;P:0;S:0;T:0;W:0;Y:0,B:0;C:0;E:0;T:0,45554647,ALA_100_D_COREBINDING;ALA_102_D_COREBINDING;ALA_107_D_COREBINDING;ALA_31_C_COREBINDING;ASN_58_D_COREBINDING;ASP_109_D_COREBINDING;GLY_99_D_COREBINDING;LEU_32_D_COREBINDING;PRO_103_D_COREBINDING;SER_91_C_COREBINDING;SER_98_D_COREBINDING;THR_104_D_COREBINDING;TRP_49_C_COREBINDING;TYR_105_D_COREBINDING;TYR_106_D_COREBINDING;TYR_48_C_COREBINDING;TYR_90_C_COREBINDING,PHGGSWGQPHGGSWGQ,-1,0.50891006212887,,99999999,PRO_1_J_C;HIS_2_J_C;GLY_3_J_C;GLY_4_J_C;SER_5_J_C;TRP_6_J_C;GLY_7_J_C;GLN_8_J_C,"STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE 2 POM2 FAB ANTIBODY FRAGMENT"
4JZO_GH_L_27_7.pdb,4JZO,23696737,2.22,,,2.60.40.10,GH,427,L,11,GWLAGLFYQHK,TTTGGGCCCCC,44201100132,27,7,1,CCCCCCCCCCC,11,0,A:0;D:0;F:0;G:0;I:0;K:0;L:0;M:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:0;D:0;F:0;G:0;I:0;K:0;L:0;M:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,A:2;D:2;E:4;G:12;K:12;L:1;N:3;P:4;Q:4;R:3;S:20;T:4;V:1,A:28;C:8;D:12;E:13;F:11;G:21;H:4;I:9;K:11;L:26;M:3;N:10;P:21;Q:16;R:8;S:37;T:34;V:36;W:6;Y:20,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:14;E:12;G:5;H:2;T:39,B:8;C:61;E:196;G:10;H:8;T:47;b:4,27_7,A:1;D:2;F:1;G:3;I:1;K:1;L:2;M:1;N:2;Q:1;R:1;S:1;T:1;V:1;W:1;Y:1,C:3;E:9;G:3;T:6,A:0;D:0;F:0;G:0;I:0;K:0;L:0;M:0;N:0;Q:0;R:0;S:0;T:0;V:0;W:0;Y:0,C:0;E:0;G:0;T:0,99999877899,ALA_57_G_COREBINDING;ARG_102_G_COREBINDING;ASN_64_H_COREBINDING;ASN_92_H_COREBINDING;ASP_28_H_COREBINDING;ASP_49_H_COREBINDING;GLN_48_H_COREBINDING;GLY_103_G_COREBINDING;GLY_27_H_COREBINDING;GLY_49_G_COREBINDING;ILE_51_G_COREBINDING;LEU_100_G_COREBINDING;LEU_26_H_COREBINDING;LYS_29_H_COREBINDING;MET_58_G_COREBINDING;PHE_50_G_COREBINDING;SER_101_G_COREBINDING;THR_56_G_COREBINDING;TRP_89_H_COREBINDING;TYR_30_H_COREBINDING;VAL_32_G_COREBINDING,NTGWLAGLFYQHK,-1,0.533852036782814,,99999999999,GLY_1_L_C;TRP_2_L_C;LEU_3_L_C;ALA_4_L_C;GLY_5_L_C;LEU_6_L_C;PHE_7_L_C;TYR_8_L_C;GLN_9_L_C;HIS_10_L_C;LYS_11_L_C,"THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI 2 HEPATITIS C VIRUS HCV GLYCOPROTEIN E2 FAB FRAGMENT HC8427"
4XGZ_WX_w_27_3.pdb,4XGZ,26087144,2.50,,,2.60.40.10,WX,428,w,12,NLSELDRLLLEL,CGGGHHHHHHHC,200200110122,27,3,1,CCCCCCCCCCCC,12,0,A:0;G:0;H:0;I:0;L:0;S:0;Y:0,A:0;G:0;H:0;I:0;L:0;S:0;Y:0,A:1;C:2;D:2;E:4;G:12;K:11;L:1;N:2;P:4;Q:3;R:4;S:20;T:5,A:28;C:8;D:12;E:10;F:13;G:19;H:4;I:9;K:12;L:29;M:2;N:10;P:17;Q:18;R:8;S:46;T:28;V:38;W:6;Y:18,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:18;E:9;G:6;H:6;T:32,B:5;C:56;E:206;G:12;H:11;T:41;b:4,27_3,A:3;G:2;H:1;I:1;L:1;S:7;Y:7,C:3;E:9;G:6;T:4,A:0;G:0;H:0;I:0;L:0;S:0;Y:0,C:0;E:0;G:0;T:0,766776777789,ALA_104_W_COREBINDING;ALA_105_W_COREBINDING;ALA_28_X_COREBINDING;GLY_100_W_COREBINDING;GLY_103_W_COREBINDING;HIS_36_W_COREBINDING;ILE_92_X_COREBINDING;LEU_91_X_COREBINDING;SER_33_W_COREBINDING;SER_34_W_COREBINDING;SER_51_W_COREBINDING;SER_87_X_COREBINDING;SER_88_X_COREBINDING;SER_89_X_COREBINDING;SER_90_X_COREBINDING;TYR_101_W_COREBINDING;TYR_102_W_COREBINDING;TYR_32_W_COREBINDING;TYR_53_W_COREBINDING;TYR_55_W_COREBINDING;TYR_56_W_COREBINDING;TYR_60_W_COREBINDING,NLSELDRLLLELNAVQHNP,-1,0.577395607206721,,999999999999,ASN_1_w_C;LEU_2_w_C;SER_3_w_C;GLU_4_w_C;LEU_5_w_C;ASP_6_w_C;ARG_7_w_C;LEU_8_w_C;LEU_9_w_C;LEU_10_w_C;GLU_11_w_C;LEU_12_w_C,"CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB 2 FRAGMENT"
4ZTO_IM_Q_27_9.pdb,4ZTO,26251831,2.30,,,2.60.40.10,IM,435,Q,10,GKAMYAPPIR,CCCCCCCCCC,4202102314,27,9,1,CCCCCCCCCC,10,0,A:0;D:0;E:0;F:0;G:0;I:0;S:0;T:0;V:0;Y:0,A:0;D:0;E:0;F:0;G:0;I:0;S:0;T:0;V:0;Y:0,A:5;C:1;D:4;E:1;F:1;G:13;K:8;N:2;P:8;Q:4;S:14;T:14;W:1;Y:1,A:25;C:14;D:10;E:10;F:11;G:25;H:2;I:9;K:10;L:27;M:3;N:11;P:20;Q:16;R:8;S:28;T:47;V:39;W:6;Y:17,C:0;E:0;T:0;b:0,C:0;E:0;T:0;b:0,B:1;C:18;E:11;G:8;H:2;T:37,B:6;C:60;E:208;G:10;H:4;T:47;b:3,27_9,A:1;D:2;E:1;F:1;G:2;I:2;S:2;T:2;V:2;Y:5,C:4;E:5;T:10;b:1,A:0;D:0;E:0;F:0;G:0;I:0;S:0;T:0;V:0;Y:0,C:0;E:0;T:0;b:0,8656545566,ALA_28_M_COREBINDING;ASP_30_M_COREBINDING;ASP_54_I_COREBINDING;GLU_58_I_COREBINDING;GLY_103_I_COREBINDING;GLY_94_M_COREBINDING;ILE_29_M_COREBINDING;ILE_55_I_COREBINDING;PHE_31_I_COREBINDING;SER_95_M_COREBINDING;SER_96_M_COREBINDING;THR_101_I_COREBINDING;THR_56_I_COREBINDING;TYR_102_I_COREBINDING;TYR_32_M_COREBINDING;TYR_33_I_COREBINDING;TYR_60_I_COREBINDING;TYR_92_M_COREBINDING;VAL_52_I_COREBINDING;VAL_93_M_COREBINDING,VGKAMYAPPIRGQIR,-1,0.45824019272204,,9999999999,GLY_1_Q_C;LYS_2_Q_C;ALA_3_Q_C;MET_4_Q_C;TYR_5_Q_C;ALA_6_Q_C;PRO_7_Q_C;PRO_8_Q_C;ILE_9_Q_C;ARG_10_Q_C,"FABEPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 2 TARGETING AN EPITOPE IN HIV1 GP120 C4 REGION"
